IBDEI10H ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16825,1,3,0)
 ;;=3^Calculus of Lower Urinary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,16825,1,4,0)
 ;;=4^N21.9
 ;;^UTILITY(U,$J,358.3,16825,2)
 ;;=^5015613
 ;;^UTILITY(U,$J,358.3,16826,0)
 ;;=N20.9^^88^855^4
 ;;^UTILITY(U,$J,358.3,16826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16826,1,3,0)
 ;;=3^Calculus,Urinary,Unspec
 ;;^UTILITY(U,$J,358.3,16826,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,16826,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,16827,0)
 ;;=N28.9^^88^855^6
 ;;^UTILITY(U,$J,358.3,16827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16827,1,3,0)
 ;;=3^Kidney & Ureter Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16827,1,4,0)
 ;;=4^N28.9
 ;;^UTILITY(U,$J,358.3,16827,2)
 ;;=^5015630
 ;;^UTILITY(U,$J,358.3,16828,0)
 ;;=I12.9^^88^855^7
 ;;^UTILITY(U,$J,358.3,16828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16828,1,3,0)
 ;;=3^Kidney Disease,Chr,Hypertensive w/ Stage 1-4 or UNSPEC
 ;;^UTILITY(U,$J,358.3,16828,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,16828,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,16829,0)
 ;;=N18.1^^88^855^8
 ;;^UTILITY(U,$J,358.3,16829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16829,1,3,0)
 ;;=3^Kidney Disease,Chr,Stage 1
 ;;^UTILITY(U,$J,358.3,16829,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,16829,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,16830,0)
 ;;=N18.2^^88^855^9
 ;;^UTILITY(U,$J,358.3,16830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16830,1,3,0)
 ;;=3^Kidney Disease,Chr,Stage 2
 ;;^UTILITY(U,$J,358.3,16830,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,16830,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,16831,0)
 ;;=N18.3^^88^855^10
 ;;^UTILITY(U,$J,358.3,16831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16831,1,3,0)
 ;;=3^Kidney Disease,Chr,Stage 3
 ;;^UTILITY(U,$J,358.3,16831,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,16831,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,16832,0)
 ;;=N18.4^^88^855^11
 ;;^UTILITY(U,$J,358.3,16832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16832,1,3,0)
 ;;=3^Kidney Disease,Chr,Stage 4
 ;;^UTILITY(U,$J,358.3,16832,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,16832,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,16833,0)
 ;;=N18.5^^88^855^12
 ;;^UTILITY(U,$J,358.3,16833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16833,1,3,0)
 ;;=3^Kidney Disease,Chr,Stage 5
 ;;^UTILITY(U,$J,358.3,16833,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,16833,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,16834,0)
 ;;=N18.9^^88^855^13
 ;;^UTILITY(U,$J,358.3,16834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16834,1,3,0)
 ;;=3^Kidney Disease,Chr,Unspec
 ;;^UTILITY(U,$J,358.3,16834,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,16834,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,16835,0)
 ;;=N18.6^^88^855^5
 ;;^UTILITY(U,$J,358.3,16835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16835,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,16835,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,16835,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,16836,0)
 ;;=N17.9^^88^855^14
 ;;^UTILITY(U,$J,358.3,16836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16836,1,3,0)
 ;;=3^Kidney Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,16836,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,16836,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,16837,0)
 ;;=N19.^^88^855^15
 ;;^UTILITY(U,$J,358.3,16837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16837,1,3,0)
 ;;=3^Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,16837,1,4,0)
 ;;=4^N19.
 ;;^UTILITY(U,$J,358.3,16837,2)
 ;;=^5015607
 ;;^UTILITY(U,$J,358.3,16838,0)
 ;;=N26.1^^88^855^16
 ;;^UTILITY(U,$J,358.3,16838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16838,1,3,0)
 ;;=3^Kidney,Atrophy
